Please login to the form below

Not currently logged in

Eisai’s US division promotes Shaji Procida to chief financial officer

Will oversee pharma firm’s financial operations in the US

Shaji Procida - Eisai IncShaji Procida has been named the new VP and chief financial officer of Japanese pharma firm Eisai's US subsidiary.

In her new position, she will oversee all of Eisai Inc's financial operations in the US, as well serving on the company's executive committee.

Procida joined Eisai as its financial consolidations and reporting manager in 1998 and went on to hold various positions in finance and accounting, most recently serving as VP of finance.

"Shaji is a consummate professional who has been a key advisor within our organisation," said Lonnel Coats, president and CEO of Eisai Inc.

"Her expertise and business leadership will continue to ensure our company's financial well-being as well as support our ongoing efforts to achieve our human health care mission of helping to improve the lives of patients and their families."

In addition to her career at Eisai, Procida is also is a member of the Financial Executive Institute and the Healthcare Businesswomen's Association (HBA). In 2006, she was recognised as a 'rising star' by the HBA at its annual Woman of the Year event.

27th June 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Hayward Medical Communications

Hayward Medical Communications has been supporting partners in every sector of the healthcare industry to deliver evidence-based, clinically relevant and...

Latest intelligence

What pharma marketers can learn from behavioural science
Pharma behavioural science and traditional emotional marketing create a powerful mix of techniques that have impact on real lives....
NEW EU DATA PROTECTION REGULATION POISED TO CHANGE DATA PRIVACY LANDSCAPE The bold digital clock featured on the EUGDPR (EU General Data Protection Regulation)1 website indicates – to the second...
Health knowledge: Why is it so important?
Health knowledge plays an important role in population health, but by itself is rarely enough to prompt a change in the behaviours that cause the risks....